Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compartmentalization of ceramide signaling: physical foundations and biological effects.

Journal of cellular physiology·2000
Same author

[VIGILA: a tool for the epidemiologic surveillance of transmissible diseases].

Revista cubana de medicina tropical·2000
Same author

HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family.

Tissue antigens·2000
Same author

Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.

Antimicrobial agents and chemotherapy·2000
Same author

A randomized field trial of ACINDES: a child-centered training model for children with chronic illnesses (asthma and epilepsy).

Journal of urban health : bulletin of the New York Academy of Medicine·2000
Same author

When goodbye precedes hello: a "premature" termination.

Harvard review of psychiatry·2000

Related Experiment Video

Updated: Jul 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

[Brachyterapy in localized prostate cancer].

J M Abascal Junquera1, M Hevia Suarez, J M Abascal García

  • 1Servicio Urología, Hospital Universitario Central de Asturias, Oviedo. josuvargas@hotmail.com

Actas Urologicas Espanolas
|September 28, 2007
PubMed
Summary
This summary is machine-generated.

Low Dose Rate (LDR) Brachytherapy using Iodine-125 seeds is a minimally invasive option for localized prostate cancer. This study shows a low morbidity rate over 7.5 years in 800 patients.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: Jul 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Area of Science:

  • Oncology
  • Urology
  • Radiation Oncology

Background:

  • Localized prostate cancer necessitates effective treatment options.
  • Minimally invasive techniques are increasingly preferred over traditional surgery.
  • Low Dose Rate (LDR) Brachytherapy with Iodine-125 (1125) seeds is a prominent alternative.

Purpose of the Study:

  • To present the long-term experience with LDR brachytherapy for prostate cancer.
  • To analyze treatment outcomes and patient morbidity over a 7.5-year period.
  • To evaluate the efficacy and safety of Iodine-125 seed brachytherapy.

Main Methods:

  • A cohort of 800 patients with localized prostate cancer was treated.
  • The average patient age was 68 years (range: 48-83 years).
  • Iodine-125 seeds were implanted using Rapid-Strand and intraoperative planning.

Main Results:

  • Urinary complications included 3% acute urinary retention (AUR) and 0.2% urinary incontinence.
  • Digestive morbidity comprised 12% intermittent bleeding, 2% proctitis, and 0.3% rectal fistulas.
  • The overall complication rates indicate a favorable safety profile.

Conclusions:

  • LDR brachytherapy with Iodine-125 seeds offers a safe and effective treatment for localized prostate cancer.
  • The technique demonstrates a low incidence of significant urinary and digestive side effects.
  • Long-term data supports LDR brachytherapy as a viable alternative to surgery.